癌抗原125联合癌抗原199检测在宫颈癌诊断中的价值分析(2)
第1页 |
参见附件。
[2] Burnett T L,Pearlman M D.The effect of levonorgestrel intrauterine device placement on serum CA-125 levels in healthy premenopausal women[J].Int J Gynaecol Obstet,2014,124(2):179-180.
[3] Antonsen S L,H?gdall E,Christensen I J,et al.HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)[J].Acta Obstet Gynecol Scand,2013,92(11):1313-1322.
[4] Ikeda S,Yoshimura K,Onda T,et al.Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix[J].J Obstet Gynaecol Res,2012,38(10):1260-1265.
[5]康一青,欧阳新华,何丹,等.宫颈细胞DNA超早期筛查宫颈病变的临床分析[J].中国医学创新,2013,10(9):134-135.
[6] Fader A N,Java J,Krivak T C,et al.The prognostic significance of pre-and post-treatment CA-125 in grade 1 serous ovarian carcinoma:a gynecologic Oncology Group study[J].Gynecol Oncol,2014,132(3):560-565.
[7]郎景和.妇科肿瘤标志物及其应用[J].中国实用妇科与产科杂志,2000,16(60):323-324.
[8]沈智君,余剑敏,万雄萍.血清CA125、CA199在妇科盆腔肿瘤中的表达及意义[J].中国药物与临床,2010,10(6):717-718.
[9] Wang X F,Wu Y H,Wang M S,et al.CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause [J].Asian Pac J Cancer Prev,2014,15(1):363-368.
[10] Polat E, Duman U, Duman M, et al.Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer[J].Curr Oncol,2014, 21(1):1-7.
(收稿日期:2014-05-12) (编辑:何玉勤)
您现在查看是摘要介绍页,详见PDF附件。